D
Arcus Biosciences, Inc. RCUS
$9.34 -$0.20-2.10%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 120.51% 119.17% 104.13% 99.16% 4.46%
Total Other Revenue -- -- -- -- --
Total Revenue 120.51% 119.17% 104.13% 99.16% 4.46%
Cost of Revenue 29.43% 32.94% 19.03% -4.87% -7.99%
Gross Profit 42.57% 45.45% 62.70% 70.37% 15.91%
SG&A Expenses 2.56% 4.31% 8.04% 8.18% 12.50%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 24.29% 26.64% 19.82% 16.51% 16.58%
Operating Income 8.82% 7.74% 12.78% 16.39% -21.43%
Income Before Tax 6.31% 6.60% 13.38% 18.05% -13.16%
Income Tax Expenses -83.33% -80.00% 0.00% 100.00% 500.00%
Earnings from Continuing Operations 7.82% 7.85% 13.24% 17.20% -14.98%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 7.82% 7.85% 13.24% 17.20% -14.98%
EBIT 8.82% 7.74% 12.78% 16.39% -21.43%
EBITDA 9.64% 9.15% 13.73% 17.47% -21.17%
EPS Basic 25.36% 21.06% 21.42% 19.46% -11.88%
Normalized Basic EPS 29.85% 25.94% 27.56% 26.35% -10.11%
EPS Diluted 25.36% 21.09% 21.45% 19.49% -11.83%
Normalized Diluted EPS 29.85% 25.94% 27.56% 26.35% -10.11%
Average Basic Shares Outstanding 21.84% 17.14% 12.34% 6.70% 2.78%
Average Diluted Shares Outstanding 21.84% 17.14% 12.34% 6.70% 2.78%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings